VJHemOnc is committed to improving our service to you

MDS 2020 | Erythropoiesis-stimulating agents in MDS

VJHemOnc is committed to improving our service to you

Valeria Santini

Valeria Santini, MD, University of Florence, Florence, Italy, outlines the impact of different doses of erythropoiesis-stimulating agents in patients with myelodysplastic syndromes (MDS) in an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter